A new molecule developed by University at Buffalo researchers acts like a local, long-lasting anesthetic, providing robust ...

Pain assessment is an important element of acute pain management and highly recommended by several guidelines. Traditionally, pain is assessed by asking patients to rate their pain intensity on a ...

A study conducted at the State University of Campinas (UNICAMP) in Brazil investigated the process of muscle pain chronification—that is, when it goes from acute to chronic—and identified one ...

The novel fast-acting meloxicam formulation is in development for moderate-to-severe acute pain following herniorrhaphy and bunionectomy surgeries. According to the company, full results from the ...

the largest nursing school in the U.S., has partnered with the American Association of Post-Acute Care Nursing to offer a post-acute care specialty training course. The partnership was announced ...

patients with acute myocarditis (AM) had a significantly higher risk for 30-day and long-term mortality than those with unexplained chest pain. Despite rigorous validation of the registry ...

After surgery, you’ll likely experience acute pain around the procedure site. Various pain management techniques can help you cope as you heal from your surgery. Managing pain after a surgical ...

The new drug is intended for treatment of moderate to severe acute pain in adults. Patients with acute pain after surgery or due to a broken bone or an injury are often prescribed opioid ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid painkiller that could change the way doctors treat acute pain.

Perspective from Anita Gupta, DO, PharmD, MPP, GMP, FASA The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.

Vertex Pharmaceuticals claimed in a press release that the medication can be used for many types of moderate-to-severe acute pain and has shown no evidence that it is addictive, like opioids.

Jan. 31, 2025 – The FDA has approved a new non-opioid oral drug for acute pain in adults. It is the first new class of non-opioid pain medicine approved in over 20 years, providing effective ...